Share on StockTwits

Onconova Therapeutics (NASDAQ:ONTX) CEO Ramesh Kumar sold 60,000 shares of the stock on the open market in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $15.05, for a total transaction of $903,000.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Shares of Onconova Therapeutics (NASDAQ:ONTX) traded down 0.46% on Monday, hitting $15.05. The stock had a trading volume of 364,867 shares. Onconova Therapeutics has a 52 week low of $10.80 and a 52 week high of $31.13. The stock’s 50-day moving average is $12.85 and its 200-day moving average is $19.19. The company’s market cap is $322.2 million.

Onconova Therapeutics (NASDAQ:ONTX) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($1.34) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.66) by $0.68. The company had revenue of $1.12 million for the quarter, compared to the consensus estimate of $1.07 million. Analysts expect that Onconova Therapeutics will post $-5.36 EPS for the current fiscal year.

Onconova Therapeutics, Inc (NASDAQ:ONTX) is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule drug candidates to treat cancer.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.